NCT02430311View on ClinicalTrials.gov

The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 10, 2015

Primary Completion Date

July 27, 2016

Study Completion Date

April 28, 2017

Conditions
Advanced Solid Tumours
Interventions
DRUG

Olaparib

Tablet-150mg, Oral

DRUG

Paclitaxel

Injection

DRUG

Olaparib

Tablet-100mg, Oral

Trial Locations (3)

100021

Research Site, Beijing

100071

Research Site, Beijing

310003

Research Site, Hangzhou

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY